Literature DB >> 15569398

Treatment of Raynaud's phenomenon with escitalopram.

Ansgar Buecking, Estelle Rougemont, Daniele Fabio Zullino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15569398     DOI： 10.1017/S1461145704004882

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN： 1461-1457            Impact factor:   5.176


× No keyword cloud information.
  4 in total

1.  Citalopram-induced Raynaud's phenomenon.

Authors:  A M Peiró; C Margarit; M Torra
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

Review 2.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

Review 3.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

Review 4.  Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.

Authors:  Iqra Nawaz; Yashfa Nawaz; Eisha Nawaz; Muhammad Romail Manan; Adil Mahmood
Journal:  Cureus       Date:  2022-01-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.